• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脐带来源间充质基质细胞的分离、扩增及鉴定:确定实验功能传代的方法

Isolation, Expansion, and Characterization of Wharton's Jelly-Derived Mesenchymal Stromal Cell: Method to Identify Functional Passages for Experiments.

作者信息

Aung Shuh-Wen, Abu Kasim Noor Hayaty, Ramasamy Thamil Selvee

机构信息

Department of Restorative Dentistry, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.

Regenerative Dentistry Research Group, Faculty of Dentistry, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

Methods Mol Biol. 2019;2045:323-335. doi: 10.1007/7651_2019_242.

DOI:10.1007/7651_2019_242
PMID:31201682
Abstract

The therapeutic potential of human mesenchymal stromal stem cells (hMSCs) for cell-based therapeutic is greatly influenced by the in vitro culture condition including the culture conditions. Nevertheless, there are many technical challenges needed to be overcome prior to the clinical use including the quantity, quality, and heterogeneity of the cells. Therefore, it is necessary to develop a stem cell culture procedure or protocol for cell expansion in order to generate reproducible and high-quality cells in accordance with good manufacturing practice for clinical and therapeutic purposes. Here we assessed the MSCs characteristic of human Wharton's jelly mesenchymal stromal cells in in vitro culture according to the criteria established by the International Society for Cellular Therapy. Besides, the viability of the WJMSCs was determined in order to increase the confidence that the cells are employed to meet the therapeutic efficacy.

摘要

人间充质基质干细胞(hMSCs)用于基于细胞的治疗的治疗潜力受到包括培养条件在内的体外培养条件的极大影响。然而,在临床应用之前,仍有许多技术挑战需要克服,包括细胞的数量、质量和异质性。因此,有必要开发一种用于细胞扩增的干细胞培养程序或方案,以便根据临床和治疗目的的良好生产规范生成可重复且高质量的细胞。在此,我们根据国际细胞治疗协会制定的标准,评估了体外培养的人脐带华通氏胶间充质基质细胞的间充质干细胞特性。此外,还测定了WJMSCs的活力,以增强对所使用细胞达到治疗效果的信心。

相似文献

1
Isolation, Expansion, and Characterization of Wharton's Jelly-Derived Mesenchymal Stromal Cell: Method to Identify Functional Passages for Experiments.脐带来源间充质基质细胞的分离、扩增及鉴定:确定实验功能传代的方法
Methods Mol Biol. 2019;2045:323-335. doi: 10.1007/7651_2019_242.
2
Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.人脐带华通氏胶来源间充质干细胞的特性及其在非支架组织工程软骨构建中的应用。
J Biosci Bioeng. 2014 Feb;117(2):229-235. doi: 10.1016/j.jbiosc.2013.07.001. Epub 2013 Jul 27.
3
Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.从牛脐带中分离和鉴定 Wharton's 胶源多能间充质基质细胞,并在无血清三维体系中维持。
BMC Biotechnol. 2012 May 4;12:18. doi: 10.1186/1472-6750-12-18.
4
Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.通过外植体培养法从完整脐带和华通氏胶基质中分离的人间充质干细胞的比较。
Cell Tissue Bank. 2014 Dec;15(4):555-65. doi: 10.1007/s10561-014-9425-1. Epub 2014 Feb 17.
5
Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.细胞周期和WNT信号通路相关基因的差异表达导致了脐带来源间充质干细胞与骨髓来源间充质干细胞在生长和分化潜能上的差异。
Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9.
6
Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.比较分析同一脐带不同部位来源的人脐带华通氏胶间充质干细胞。
Cell Tissue Res. 2018 Apr;372(1):51-65. doi: 10.1007/s00441-017-2699-4. Epub 2017 Dec 4.
7
Assessment of the Neuroprotective and Stemness Properties of Human Wharton's Jelly-Derived Mesenchymal Stem Cells under Variable (5% vs. 21%) Aerobic Conditions.评估人脐带华通氏胶间充质干细胞在不同(5%与 21%)有氧条件下的神经保护和干性特性。
Cells. 2021 Mar 24;10(4):717. doi: 10.3390/cells10040717.
8
A GMP-compliant manufacturing method for Wharton's jelly-derived mesenchymal stromal cells.符合 GMP 标准的人脐带华通氏胶源间充质基质细胞制造方法。
Stem Cell Res Ther. 2024 May 3;15(1):131. doi: 10.1186/s13287-024-03725-0.
9
Wharton's Jelly Derived-Mesenchymal Stem Cells: Isolation and Characterization.源自华通氏胶的间充质干细胞:分离与鉴定
Acta Med Iran. 2018 Jan;56(1):28-33.
10
3D Decellularized Native Extracellular Matrix Scaffold for In Vitro Culture Expansion of Human Wharton's Jelly-Derived Mesenchymal Stem Cells (hWJ MSCs).用于人脐带华通氏胶源性间充质干细胞(hWJ MSCs)体外培养扩增的3D去细胞化天然细胞外基质支架
Methods Mol Biol. 2018;1577:35-53. doi: 10.1007/7651_2017_71.

引用本文的文献

1
Enhancing bone tissue engineering with polyacrylonitrile electrospun scaffolds and graphene quantum dots: A comprehensive approach to regenerative medicine.用聚丙烯腈电纺支架和石墨烯量子点增强骨组织工程:再生医学的综合方法。
Bioimpacts. 2025 Jul 1;15:30835. doi: 10.34172/bi.30835. eCollection 2025.
2
Wharton's jelly-derived mesenchymal stem cells ameliorate high altitude-induced heart injury by promoting type 2 macrophage polarization via COX2-PGE2 pathway.沃顿胶源性间充质干细胞通过COX2-PGE2途径促进2型巨噬细胞极化,改善高原诱导的心脏损伤。
Front Immunol. 2025 Jun 6;16:1538046. doi: 10.3389/fimmu.2025.1538046. eCollection 2025.
3
Alterations in apoptotic pathways and expression of miR-134, miR-181, and miR-497 induced by Wharton's jelly-derived mesenchymal stem cells in a rat model of ischemic brain injury.
在缺血性脑损伤大鼠模型中,脐带来源的间充质干细胞诱导的凋亡途径及miR-134、miR-181和miR-497表达的改变
IBRO Neurosci Rep. 2025 Apr 28;18:759-770. doi: 10.1016/j.ibneur.2025.04.015. eCollection 2025 Jun.
4
Therapeutic Mesenchymal Stem/Stromal Cells: Value, Challenges and Optimization.治疗性间充质干/基质细胞:价值、挑战与优化
Front Cell Dev Biol. 2022 Jan 14;9:716853. doi: 10.3389/fcell.2021.716853. eCollection 2021.